The propofol prodrug GPI 15715 [Aquavan] has achieved its phase-III primary efficacy endpoint

By  

Inpharma, Vol. 1, Iss. 1482, 2005-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Nemonoxacin met the primary endpoint of noninferiority versus levofloxacin for community-acquired pneumonia

By  

Inpharma, Vol. 1, Iss. 1634, 2008-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Discovery of Dual Orexin Receptor Antagonists (DORAs) for the Treatment of Insomnia

By  

Current Topics in Medicinal Chemistry, Vol. 11, Iss. 6, 2011-03 ,pp. : 696-725

Bentham Science Publishers

Access to resources Recommend Favorite

Modular Branched Neurotensin Peptides for Tumor Target Tracing and Receptor-Mediated Therapy: A Proof-of-Concept

By  

Current Cancer Drug Targets, Vol. 10, Iss. 7, 2010-11 ,pp. : 695-704

Bentham Science Publishers

Access to resources Recommend Favorite

An Overview of the Actions of Capsaicin and Its Receptor, TRPV1, and Their Relations to Small Primary Sensory Neurons

By  

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents), Vol. 10, Iss. 1, 2011-02 ,pp. : 2-9

Bentham Science Publishers

Access to resources Recommend Favorite